Skip to main content

Table 3 Baseline features of the studies which were included

From: Stent thrombosis associated with drug eluting stents on addition of cilostazol to the standard dual antiplatelet therapy following percutaneous coronary intervention: a systematic review and meta-analysis of published randomized controlled trials

Studies

Age (years)

Males (%)

HT (%)

Ds (%)

DM (%)

Cs (%)

 

DT/TT

DT/TT

DT/TT

DT/TT

DT/TT

DT/TT

Ahn2008 [10]

62.0/61.2

54.7/61.7

54.0/48.9

25.2/19.1

100/100

34.5/39.5

Gao2013 [11]

55.3/57.6

81.9/78.9

54.4/56.3

21.4/24.9

16.2/19.2

42.3/38.5

Han2009 [12]

60.2/59.6

72.9/73.8

56.1/57.9

45.4/45.5

20.1/23.3

Lee2005 [13]

59.0/59.0

71.8/71.8

46.1/42.3

27.6/26.8

26.2/23.4

31.9/32.4

Lee2010A [14]

61.0/60.9

60.7/62.2

57.1/57.0

28.5/30.2

62.4/63.3

34.7/31.6

Lee2011 [15]

62.1/60.9

71.5/70.0

64.7/58.4

45.0/42.4

33.7/36.8

30.1/30.4

Suh2011 [16]

64.0/64.8

68.3/68.6

66.6/64.5

32.2/35.5

26.8/23.7

Youn2014 [17]

64.2/65.0

64.2/63.0

65.8/68.2

47.6/49.4

30.9/32.5

44.0/48.4

Zhu2015 [18]

60.1/60.2

64.9/66.9

45.7/41.6

57.0/51.3

21.9/17.5

32.5/39.0

Park2013 [19]

63.7/62.8

67.0/69.8

68.6/66.8

62.7/64.2

31.3/31.8

30.8/32.8

  1. Abbreviations: DT: Dual antiplatelet therapy, TT: Triple antiplatelet therapy, HT: Hypertension, ds: Dyslipidemia, DM: Diabetes mellitus, Cs: Current smoker